Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.45M Sell
26,396
-837
-3% -$77.8K 0.02% 615
2026
Q1
$2.65M Buy
27,233
+3,178
+13% +$291K 0.02% 542
2025
Q4
$2.12M Buy
24,055
+954
+4% +$86.9K 0.02% 560
2025
Q3
$2.08M Buy
23,101
+2,899
+14% +$235K 0.02% 568
2025
Q2
$1.53M Buy
20,202
+790
+4% +$58.7K 0.02% 596
2025
Q1
$1.39M Buy
19,412
+3,474
+22% +$271K 0.02% 602
2024
Q4
$1.4M Buy
15,938
+3,284
+26% +$287K 0.02% 525
2024
Q3
$1.06M Buy
12,654
+1,289
+11% +$103K 0.03% 607
2024
Q2
$864K Buy
11,365
+2,547
+29% +$188K 0.02% 643
2024
Q1
$633K Buy
8,818
+4,072
+86% +$292K 0.01% 728
2023
Q4
$355K Buy
4,746
+911
+24% +$65.2K 0.01% 922
2023
Q3
$261K Buy
+3,835
New +$277K 0.01% 989

Other funds holding SRE

Vident Advisory's SRE Position: Q2 2026 in Review

Vident Advisory reduced its Sempra (SRE) stake by 3.1% in Q2 2026, selling an estimated $77.8K and leaving 26,396 shares worth $2.45M. The position accounts for 0.02% of the portfolio, ranked #615.

Vident Advisory first reported a position in SRE in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.65M in Q1 2026. 1,282 funds tracked by Wall St. Rank hold SRE as of Q2 2026.

  • Vident Advisory held 26,396 shares of Sempra worth $2.45M as of Q2 2026.
  • Vident Advisory sold 837 Sempra shares in Q2 2026, an estimated $77.8K.
  • Sempra made up 0.02% of Vident Advisory's portfolio in Q2 2026, its #615 holding.
  • Vident Advisory first reported a position in Sempra in Q3 2023 and has held it in 12 quarters since.
  • Vident Advisory's Sempra position peaked at $2.65M in Q1 2026.
  • 1,282 funds tracked by Wall St. Rank held Sempra as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.